For the treatment of: Major Depressive Disorder (MDD); Obsessive-Compulsive Disorder; Bulimia Nervosa; Panic Disorder; Premenstrual Dysphoric Disorder (a severe form of PMS).
In combination with olanzapine: Acute treatment of depressive episodes associated with bipolar I disorder in adult patients: Fluoxetine monotherapy is not indicated for the treatment of depressive episodes associated with bipolar I disorder.
Acute treatment of Treatment Resistant Depression in adults (defined as MDD in adult patients who do not respond to two separate trials of different antidepressants of adequate dose and duration in the current episode): Fluoxetine monotherapy is not indicated for the treatment of treatment resistant depression.